Home › Funds › ABN AMRO Bank N.V. › EW
ABN AMRO Bank N.V. position in EW
EDWARDS LIFESCIENCES CORP · Health Care
ABN AMRO Bank N.V. reported holding 988,115 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$85.1M, representing 1.02% of its reported portfolio and ranking #32 among its reported holdings. ABN AMRO Bank N.V. has disclosed EW holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ABN AMRO Bank N.V.'s EW position evolved
ABN AMRO Bank N.V. first disclosed a stake in EW in Q3 2023 at 138,605 shares (US$9.6M). The position peaked in Q3 2026 at 988,115 shares, worth US$85.1M. Across 12 filings, ABN AMRO Bank N.V. increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 988,115 shares valued at US$85.1M — an increase of 63,801 shares quarter over quarter.. Notable position changes include a 125% increase in Q1 2026 (shares rose 13% over the following quarter), a 132% increase in Q2 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 138.60K | $9.60M | New |
| Q4 2023 | 169.45K | $12.99M | Add |
| Q1 2024 | 175.68K | $16.81M | Add |
| Q2 2024 | 173.58K | $16.17M | Reduce |
| Q3 2024 | 173.20K | $11.33M | Hold |
| Q4 2024 | 175.22K | $12.85M | Add |
| Q2 2025 | 177.71K | $14.00M | New |
| Q3 2025 | 179.60K | $13.93M | Add |
| Q4 2025 | 177.46K | $15.08M | Reduce |
| Q1 2026 | 398.43K | $32.25M | Add |
| Q2 2026 | 924.31K | $83.57M | Add |
| Q3 2026 | 988.12K | $85.08M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- Belvedere Trading LLC 3.30M sh · $25.63B · Q3 2026
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M sh · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M sh · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.09M sh · $525.69M · Q3 2026
More on ABN AMRO Bank N.V.
FAQ
How long has ABN AMRO Bank N.V. held EW?
ABN AMRO Bank N.V. has disclosed EW holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
What is ABN AMRO Bank N.V.'s current position in EW?
As of Q3 2026, ABN AMRO Bank N.V. holds 988.12K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $85.08M, representing 1.02% of its reported portfolio and ranking #32.
Has ABN AMRO Bank N.V. been buying or selling EW?
In the latest 13F filing (Q3 2026), ABN AMRO Bank N.V. increased its position in EW. The position peaked in Q3 2026 at 988.12K shares.
Which other funds hold EW?
Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.